Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
MiNK Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| AGENUS INC (10% Owner) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Bought 15,001 shares
@ $1.0919, valued at
$16.4k
|
|
| 10/03/2023 |
4
| Buell Jennifer (CEO) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 25,000 shares
@ $1.1538, valued at
$28.8k
Paid exercise price by delivering 58,550 shares
@ $1.0445, valued at
$61.2k
Paid exercise price by delivering 65,000 shares
@ $0.9449, valued at
$61.4k
|
|
| 09/29/2023 |
4
| Buell Jennifer (CEO) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Exercised 695,750 restricted stock units
@ $0 |
|
| 06/16/2023 |
4
| Behner Peter (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 22,500 options to buy
@ $2.27, valued at
$51.1k
|
|
| 06/16/2023 |
4
| Ryan Barbara (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 37,500 options to buy
@ $2.27, valued at
$85.1k
|
|
| 06/16/2023 |
4
| Corvese Brian (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 37,500 options to buy
@ $2.27, valued at
$85.1k
|
|
| 06/16/2023 |
4
| Baldoni John (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 22,500 options to buy
@ $2.27, valued at
$51.1k
|
|
| 06/16/2023 |
4
| WIINBERG ULF (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 22,500 options to buy
@ $2.27, valued at
$51.1k
|
|
| 06/02/2023 |
4
| Corvese Brian (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 10,157 shares
@ $1.76, valued at
$17.9k
|
|
| 06/02/2023 |
4
| Ryan Barbara (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 10,086 shares
@ $1.76, valued at
$17.8k
|
|
| 06/02/2023 |
4
| Behner Peter (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 8,736 shares
@ $1.76, valued at
$15.4k
|
|
| 06/02/2023 |
4
| WIINBERG ULF (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 7,955 shares
@ $1.76, valued at
$14k
|
|
| 06/02/2023 |
4
| Baldoni John (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 8,168 shares
@ $1.76, valued at
$14.4k
|
|
| 05/26/2023 |
4/A
| ARMEN GARO H (Director) has filed a Form 4 on MiNK Therapeutics, Inc. |
| 05/26/2023 |
4/A
| AGENUS INC (10% Owner) has filed a Form 4 on MiNK Therapeutics, Inc. |
| 05/26/2023 |
4/A
| AGENUS INC (10% Owner) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Disposed of 5,006,397 shares
@ $0 |
|
| 05/12/2023 |
4
| AGENUS INC (10% Owner) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Bought 22,065 shares
@ $1.509, valued at
$33.3k
Bought 23,361 shares
@ $1.4275, valued at
$33.3k
|
|
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2023 |
4
| AGENUS INC (10% Owner) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Bought 128,689 shares
@ $1.0789, valued at
$138.8k
Bought 21,473 shares
@ $1.2223, valued at
$26.2k
Bought 100,000 shares
@ $0.9485, valued at
$94.9k
Bought 200 shares
@ $1.25, valued at
$250 |
|
| 05/04/2023 |
4
| ARMEN GARO H (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Bought 100,000 shares
@ $0.9485, valued at
$94.9k
|
|
| 05/03/2023 |
4
| AGENUS INC (10% Owner) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Disposed of 4,988,273 shares
@ $0 |
|
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2023 |
4
| van Dijk Marcus Antonius (Chief Scientific Officer) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 51,628 shares
@ $2.32, valued at
$119.8k
Paid exercise price by delivering 24,265 shares
@ $2.32, valued at
$56.3k
|
|
| 01/11/2023 |
4
| van Dijk Marcus Antonius (Chief Scientific Officer) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 15,000 options
@ $2.32, valued at
$34.8k
|
|
| 01/11/2023 |
4
| Buell Jennifer (CEO) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 171,990 shares
@ $2.32, valued at
$399k
Granted 500,000 options
@ $2.32, valued at
$1.2M
|
|
| 12/05/2022 |
4
| WIINBERG ULF (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 5,364 shares
@ $2.61, valued at
$14k
|
|
| 12/05/2022 |
4
| Baldoni John (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 5,508 shares
@ $2.61, valued at
$14.4k
|
|
| 12/05/2022 |
4
| Corvese Brian (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 6,849 shares
@ $2.61, valued at
$17.9k
|
|
| 12/05/2022 |
4
| Ryan Barbara (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 6,801 shares
@ $2.61, valued at
$17.8k
|
|
| 12/05/2022 |
4
| Behner Peter (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 5,891 shares
@ $2.61, valued at
$15.4k
|
|
| 09/19/2022 |
4
| Baldoni John (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 10,974 shares
@ $2.62, valued at
$28.8k
|
|
| 09/19/2022 |
4
| WIINBERG ULF (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 10,688 shares
@ $2.62, valued at
$28k
|
|
| 09/19/2022 |
4
| Behner Peter (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 11,737 shares
@ $2.62, valued at
$30.8k
|
|
| 09/19/2022 |
4
| Ryan Barbara (Director) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 13,550 shares
@ $2.62, valued at
$35.5k
|
|
|
|
|